probucol ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
2269 23288-49-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • probucol
  • biphenabid
  • bisphenabid
  • phenbutol
  • lorelco
A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
  • Molecular weight: 516.84
  • Formula: C31H48O2S2
  • CLOGP: 10.97
  • LIPINSKI: 2
  • HAC: 2
  • HDO: 2
  • TPSA: 40.46
  • ALOGS: -7.09
  • ROTB: 8

  • Status: OFM

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 2 Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 27.64 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 5 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
Feb. 1, 1977 FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C10AX02 CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS
LIPID MODIFYING AGENTS, PLAIN
Other lipid modifying agents
MeSH PA D000924 Anticholesteremic Agents
MeSH PA D000963 Antimetabolites
MeSH PA D000975 Antioxidants
MeSH PA D000960 Hypolipidemic Agents
MeSH PA D057847 Lipid Regulating Agents
MeSH PA D020011 Protective Agents
CHEBI has role CHEBI:22586 antioxidants
CHEBI has role CHEBI:35472 anti-inflammatory drugs
CHEBI has role CHEBI:35554 cardiovascular agent
CHEBI has role CHEBI:35679 antilipemic drugs
CHEBI has role CHEBI:35821 anticholesteremic drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypercholesterolemia indication 13644009
Hyperlipidemia indication 55822004 DOID:1168




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.32 acidic
pKa2 11.92 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
ATP-binding cassette sub-family A member 1 Transporter INHIBITOR CHEMBL CHEMBL
Potassium voltage-gated channel subfamily H member 2 Ion channel IC50 4.69 WOMBAT-PK
Arachidonate 15-lipoxygenase Enzyme IC50 4.85 CHEMBL
NAD-dependent protein deacylase sirtuin-5, mitochondrial Enzyme IC50 5.80 CHEMBL
Serine protease hepsin Enzyme IC50 6.37 CHEMBL
Trypsin Enzyme IC50 4.47 CHEMBL

External reference:

IDSource
4018611 VUID
N0000146924 NUI
D00476 KEGG_DRUG
4018611 VANDF
C0033215 UMLSCUI
CHEBI:8427 CHEBI
CHEMBL608 ChEMBL_ID
D011341 MESH_DESCRIPTOR_UI
DB01599 DRUGBANK_ID
7277 IUPHAR_LIGAND_ID
2928 INN_ID
P3CTH044XJ UNII
4912 PUBCHEM_CID
203350 RXNORM
1235 MMSL
5357 MMSL
d00353 MMSL
002054 NDDF
32474005 SNOMEDCT_US
387178009 SNOMEDCT_US

Pharmaceutical products:

None